Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11.

Identifieur interne : 000F20 ( PubMed/Corpus ); précédent : 000F19; suivant : 000F21

An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11.

Auteurs : Sophia Ng ; Peng Wu ; Hiroshi Nishiura ; Dennis K M. Ip ; Esther S T. Lee ; Benjamin J. Cowling

Source :

RBID : pubmed:21871096

English descriptors

Abstract

Vaccination is generally considered to be the best primary prevention measure against influenza virus infection. Many countries encourage specific target groups of people to undertake vaccination, often with financial subsidies or a priority list. To understand differential patterns of national target groups for influenza vaccination before, during and after the 2009 influenza pandemic, we reviewed and analyzed the country-specific policies in the corresponding time periods.

DOI: 10.1186/1471-2334-11-230
PubMed: 21871096

Links to Exploration step

pubmed:21871096

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11.</title>
<author>
<name sortKey="Ng, Sophia" sort="Ng, Sophia" uniqKey="Ng S" first="Sophia" last="Ng">Sophia Ng</name>
<affiliation>
<nlm:affiliation>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wu, Peng" sort="Wu, Peng" uniqKey="Wu P" first="Peng" last="Wu">Peng Wu</name>
</author>
<author>
<name sortKey="Nishiura, Hiroshi" sort="Nishiura, Hiroshi" uniqKey="Nishiura H" first="Hiroshi" last="Nishiura">Hiroshi Nishiura</name>
</author>
<author>
<name sortKey="Ip, Dennis K M" sort="Ip, Dennis K M" uniqKey="Ip D" first="Dennis K M" last="Ip">Dennis K M. Ip</name>
</author>
<author>
<name sortKey="Lee, Esther S T" sort="Lee, Esther S T" uniqKey="Lee E" first="Esther S T" last="Lee">Esther S T. Lee</name>
</author>
<author>
<name sortKey="Cowling, Benjamin J" sort="Cowling, Benjamin J" uniqKey="Cowling B" first="Benjamin J" last="Cowling">Benjamin J. Cowling</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21871096</idno>
<idno type="pmid">21871096</idno>
<idno type="doi">10.1186/1471-2334-11-230</idno>
<idno type="wicri:Area/PubMed/Corpus">000F20</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F20</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11.</title>
<author>
<name sortKey="Ng, Sophia" sort="Ng, Sophia" uniqKey="Ng S" first="Sophia" last="Ng">Sophia Ng</name>
<affiliation>
<nlm:affiliation>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wu, Peng" sort="Wu, Peng" uniqKey="Wu P" first="Peng" last="Wu">Peng Wu</name>
</author>
<author>
<name sortKey="Nishiura, Hiroshi" sort="Nishiura, Hiroshi" uniqKey="Nishiura H" first="Hiroshi" last="Nishiura">Hiroshi Nishiura</name>
</author>
<author>
<name sortKey="Ip, Dennis K M" sort="Ip, Dennis K M" uniqKey="Ip D" first="Dennis K M" last="Ip">Dennis K M. Ip</name>
</author>
<author>
<name sortKey="Lee, Esther S T" sort="Lee, Esther S T" uniqKey="Lee E" first="Esther S T" last="Lee">Esther S T. Lee</name>
</author>
<author>
<name sortKey="Cowling, Benjamin J" sort="Cowling, Benjamin J" uniqKey="Cowling B" first="Benjamin J" last="Cowling">Benjamin J. Cowling</name>
</author>
</analytic>
<series>
<title level="j">BMC infectious diseases</title>
<idno type="eISSN">1471-2334</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Animals</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Health Policy</term>
<term>Humans</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Influenza, Human (transmission)</term>
<term>Influenza, Human (virology)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Orthomyxoviridae (immunology)</term>
<term>Orthomyxoviridae (isolation & purification)</term>
<term>Pandemics</term>
<term>Pregnancy</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Animals</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Health Policy</term>
<term>Humans</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
<term>Pregnancy</term>
<term>Young Adult</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Vaccination is generally considered to be the best primary prevention measure against influenza virus infection. Many countries encourage specific target groups of people to undertake vaccination, often with financial subsidies or a priority list. To understand differential patterns of national target groups for influenza vaccination before, during and after the 2009 influenza pandemic, we reviewed and analyzed the country-specific policies in the corresponding time periods.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">21871096</PMID>
<DateCompleted>
<Year>2011</Year>
<Month>12</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1471-2334</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>11</Volume>
<PubDate>
<Year>2011</Year>
<Month>Aug</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>BMC infectious diseases</Title>
<ISOAbbreviation>BMC Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11.</ArticleTitle>
<Pagination>
<MedlinePgn>230</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/1471-2334-11-230</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Vaccination is generally considered to be the best primary prevention measure against influenza virus infection. Many countries encourage specific target groups of people to undertake vaccination, often with financial subsidies or a priority list. To understand differential patterns of national target groups for influenza vaccination before, during and after the 2009 influenza pandemic, we reviewed and analyzed the country-specific policies in the corresponding time periods.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Information on prioritized groups targeted to receive seasonal and pandemic influenza vaccines was derived from a multi-step internet search of official health department websites, press releases, media sources and academic journal articles. We assessed the frequency and consistency of targeting 20 different groups within populations which are associated with age, underlying medical conditions, role or occupations among different countries and vaccines. Information on subsidies provided to specific target groups was also extracted.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">We analyzed target groups for 33 (seasonal 2009 and 2009-10 vaccines), 72 (monovalent pandemic 2009-10 vaccine) and 34 (seasonal 2010 and 2010-11 vaccines) countries. In 2009-10, the elderly, those with chronic illness and health care workers were common targets for the seasonal vaccine. Comparatively, the elderly, care home residents and workers, animal contacts and close contacts were less frequently targeted to receive the pandemic vaccine. Pregnant women, obese persons, essential community workers and health care workers, however, were more commonly targeted. After the pandemic, pregnant women, obese persons, health care and care home workers, and close contacts were more commonly targeted to receive the seasonal vaccine compared to 2009-10, showing continued influence from the pandemic. Many of the countries provided free vaccines, partial subsidies, reimbursements or national health insurance coverage to specific target groups and over one-third of the countries offered universal subsidy regarding the pandemic vaccine. There was also some inconsistency between countries in target groups.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Differences in target groups between countries may reflect variable objectives as well as uncertainties regarding the transmission dynamics, severity and age-specific immunity against influenza viruses before and after vaccination. Clarification on these points is essential to elucidate optimal and object-oriented vaccination strategies.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ng</LastName>
<ForeName>Sophia</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Peng</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nishiura</LastName>
<ForeName>Hiroshi</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ip</LastName>
<ForeName>Dennis K M</ForeName>
<Initials>DK</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Esther S T</ForeName>
<Initials>ES</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cowling</LastName>
<ForeName>Benjamin J</ForeName>
<Initials>BJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2011</Year>
<Month>08</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>BMC Infect Dis</MedlineTA>
<NlmUniqueID>100968551</NlmUniqueID>
<ISSNLinking>1471-2334</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006291" MajorTopicYN="N">Health Policy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009975" MajorTopicYN="N">Orthomyxoviridae</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2011</Year>
<Month>05</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2011</Year>
<Month>08</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2011</Year>
<Month>8</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2011</Year>
<Month>8</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2011</Year>
<Month>12</Month>
<Day>13</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">21871096</ArticleId>
<ArticleId IdType="pii">1471-2334-11-230</ArticleId>
<ArticleId IdType="doi">10.1186/1471-2334-11-230</ArticleId>
<ArticleId IdType="pmc">PMC3175216</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Clin Infect Dis. 2011 Aug 1;53(3):280-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21765076</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Hosp Infect. 2011 Aug;78(4):308-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21501896</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2003 Jan 8;289(2):179-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12517228</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Public Health Rep. 1986 Mar-Apr;101(2):205-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3083477</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 2005 Feb 15;161(4):303-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15692073</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Obstet Gynecol. 2006 Jun;107(6):1315-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16738158</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2007 Jan 15;25(5):846-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17074423</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Public Health. 2007;7:236</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17825095</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cochrane Database Syst Rev. 2008;(2):CD004879</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18425905</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2008 Oct 23;13(43). pii: 19017</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18947524</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2008;337:a2140</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18957465</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2008;337:a2142</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18957466</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2009 Aug 8;374(9688):451-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19643469</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2009 Aug 28;58(33):913-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19713879</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Top Microbiol Immunol. 2009;333:495-507</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19768421</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2009 Sep 25;325(5948):1705-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19696313</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2009 Nov 4;302(17):1896-902</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19887665</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2009 Oct 30;326(5953):729-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19745114</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Nov 12;361(20):1945-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19745214</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Nov 12;361(20):1935-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19815859</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):923-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20080777</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cochrane Database Syst Rev. 2010;(2):CD004876</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20166072</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2010;340:c1279</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20299694</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2010;5(3):e9694</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20300571</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2010 Mar 26;59(11):321-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20339343</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2010;10:145</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20513239</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cochrane Database Syst Rev. 2010;(7):CD001269</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20614424</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2010 Nov 15;51(10):1184-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20964521</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2010;5(11):e13767</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21085686</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2011 Jan;11(1):23-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21106443</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BJOG. 2000 Oct;107(10):1282-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11028582</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F20 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000F20 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:21871096
   |texte=   An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:21871096" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a PandemieGrippaleV1 

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021